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Abstract 
As a Cell and Molecular major with a Pre-Pharmacy emphasis, medicine has been an interest of 
mine. The major cause of increasing bacterial resistance to beta-lactam antibiotics is due to the 
expression of the enzyme beta-lactamase in bacteria. This leads to the inactivation of the 
antibiotics and preventing cell death. The currently known inhibitors of beta-lactamase are 
clavulanic acid, sulbactam, and tazobactam. These are the only inhibitors that have reached 
clinical importance. Phthalic acids derivatives have been identified as potential inhibitors. 
Phthalic acid, Terephthalic acid, and 1,2-Phenylenediacetic acid were tested for beta-lactamase 
inhibition at various concentrations to determine the IC50 values. The data showed that 
terephthalic acid was the most inhibitory of beta-lactamase. The IC50 for terephthalic acid was 
not fully determined, however the smallest concentration of terephthalic acid tested,1.5 mM, 
yielded a beta-lactamase activity of 34%, in other words an 66% inhibition. The IC50 values for 
phthalic acid and 1,2-Phenylenediacetic acid were 8.0 +/- 0.6 mM and 2.8 +/- 0.8 mM, 
respectively. Phthalic acid and 1,2-Phenylenediacetic acid are both similar in structure and 
inhibition of beta lactamase. Terephthalic is the most different with its carboxyl groups spread 
out the furthest. This could point towards the distance of the carboxyl groups having a greater 
impact on inhibition of beta-lactamase. Although all three phthalic acid derivatives showed the 
ability to inhibit b-lactamase, it is unlikely that these molecules would make it to the clinical level 
due to the high concentration of each molecule needed to inhibit beta-lactamase activity. 
Clinical drugs used are in the concentration of nanomolar while this experiment showed that 
millimolar concentrations were necessary for inhibition. In the future, I hope another student 
continues this research and takes a further look into the effect of the distance of the carboxyl 




Beta-lactam antibiotics work by blocking cell wall synthesis of the bacteria and are a 
common drug used to treat bacterial infections. A major problem developing today in the world 
is the increase in bacteria being resistant to beta-lactam antibiotics. (1,4) The major cause of 
increasing bacterial resistance to beta-lactam antibiotics is due to the expression of the enzyme 
beta-lactamase in bacteria (1,4). Beta-lactamase is able to hydrolyzes beta-lactam antibiotics in 
bacteria that contain the beta-lactamase coding gene(1). This leads to the inactivating of the 
antibiotics and preventing cell death. This problem has provided a challenge in finding beta-
lactamase inhibitors so these beta-lactam antibiotics can continue to kill bacterial infections. 
         There are a few inhibitors that have been found already for beta-lactamase. The 
currently know inhibitors are clavulanic acid, sulbactam, and tazobactam(2). Each of these are 
the only three inhibitors that have reached clinical importance(2). However, some other potential 
inhibitors of beta-lactamase have been identified, including phthalic acid derivatives.  
A research study performed by Yukiko Hiraiwa, Akihiro Morinaka, Takayoshi Fukushima, 
and Toshiaki Kudo has given evidence to this. In their study, they set out to find Metallo-b-
lactamase inhibitory activity of phthalic acid derivatives and found that the two carboxyl groups 
of phthalic acid derivative compounds might interact with zinc in the active site of IMP-1, which 
could then inhibit the beta-lactamase produced. They then fixed the two carboxyl groups and 
investigated the effect of substitution of the phenyl ring on metallo-beta-lactamase inhibitory 
activity.(3) In the experiment 4-butyl-3-methylphthalic acid was recognized as a metallo-beta-
lactamase inhibitor. The structure–activity relationship study of substituted phthalic acids 
afforded 3-phenylphthalic acid derivatives as potent metallo-beta-lactamase inhibitors.(3) 
 
 
Figure 1: Clavulanic acid 
 
Inhibition of beta-lactamase by clavulanate. Trapped intermediates in cryo crystallographic 























The docking simulation of Terephthalic acid at the active site of beta-lactamase (1BLC).  The 






















The docking simulation of phthalic acid at the active site of beta-lactamase (1BLC).  The 























The docking simulation of 1,2-Phenylenediacetic acid at the active site of beta-lactamase 






My proposal is to use the beta-Lactamase enzyme activity to find the beta-lactamase inhibiting 
ability for phthalic acid, 1,2-phenylenediacetic acid, and terephthalic acid. 
 
Beta-lactamase enzyme activity was assayed colorimetrically at 490 nm using the Sigma Aldrich 
Beta-Lactamase Screening Kit (MAK222).  The activity was measured by monitoring a colored 






                      
                     
                     
Figure 2: Phthalic Acid        Figure 3: 1,2-Phenylenediacetic Acid       Figure 4: Terephthalic Acid 
 
Materials and Methods 
Phthalic acid, terephthalic acid, 1,2-phenylenediacetic acid, the Beta-Lactamase Screening Kit ( 
MAK222) including beta-lactamase, beta-lactamase assay buffer and clavulanic acid, and 
nitrocefin were purchased from Sigma Aldrich. Concentrations of 500mM of Phthalic acid, 
terephthalic acid, and 1,2-phenylenediacetic acid were made using the the drugs and DMSO. 
From the 500mM concentration, concentrations of 1.5mM, 2.5mM, 5mM, 25mM, and 50mM 
were made for each drug. 30ul of enzymatic reaction mix consisting of 29uL b-Lactamase Assay 
Buffer and 1uL Nitrocefin was added to 20 uL of each drug. The drug mixtures were then 
incubated at 25 °C for 10 minutes.  A blank sample without inhibitor was ran to establish a 100% 
activity level. Clavulanic acid was also used as a known inhibitor of beta-lactamase activity to 
have a control to compare results to.  30 uL enzyme was added to initiate the reaction. The 
absorbance at 490nm was measured using a SpectraMax M5 microplate reader from Molecular 
Devices in kinetic mode for 10 minutes, taking the absorbance reading every 30 seconds. The 
data was then used to see beta-lactamase activity over time for each concentration to establish 
an activity curve. 
 
1.  Using phthalic acid and DMSO, make a 500mM concentration in order to make 
additional concentration strengths to be tested. Add 249.21mg of phthalic acid with 3mL of 
DMSO. 
2.  Make concentrations from the 500mM concentration of 1.5mM, 2.5mM, 5mM, 25mM 
50mM 
3.  To make 1.5mM solution, add 3ul of the 500mM stock solution, 750ul of beta lactamase assay 
buffer, and 247ul DMSO. Pipet 20ul into the first two wells of row A in the microplate.   
4.  To make 2.5mM solution, add 5ul of the 500mM stock solution, 750ul of beta lactamase assay 
buffer, and 245ul DMSO. Pipet 20ul into the first two wells of row B in the microplate.  
5.  To make 5mM solution, add 10ul of the 500mM stock solution, 750ul of beta lactamase assay 
buffer, and 240ul DMSO. Pipet 20ul into the first two wells of row C in the microplate.  
6.  To make 15mM solution, add 30ul of the 500mM stock solution, 750ul of beta lactamase assay 
buffer, and 220ul DMSO. Pipet 20ul into the first two wells of row D in the microplate.  
7.  To make 25mM solution, add 50ul of the 500mM stock solution, 750ul of beta lactamase assay 
buffer, and 200ul DMSO. Pipet 20ul into the first two wells of row E in the microplate.  
8.  To make 50mM solution, add 100ul of the 500mM stock solution, 750ul of beta lactamase assay 
buffer, and 150ul DMSO. 
9.  Set up Inhibition Reaction Mixes consisting of 48uL of b-Lactamase Assay buffer and 2ul 
of b-Lactamase. 50ul of the Inhibition Reaction Mix is required for each well. 
10.  Add 50ul of the appropriate Inhibition Reaction Mix to each well. Mix well by pipetting. 
11.  Incubate the plate at 25 °C for 10 minutes. Protect the plate from light during the incubation 
12.  Set up an Enzymatic Reaction Mix consisting of 29uL b-Lactamase Assay Buffer and 1uL 
Nitrocefin. 30uL of the Enzymatic Reaction Mix is required for each well. 
13.  Add 30 uL of the Enzymatic Reaction Mix to each reaction well. Mix well using a pipette. 
14.  Measure the absorbance (ABS, A490) in a microplate reader in kinetic mode for 10–30 
minutes. Take absorbance readings every minute 
  
15.  Using terephthalic acid and b-Lactamase Assay, make a 500mM concentration in order to 
make additional concentration strengths to be tested. Add 249.195mg with 3 mL of b-Lactamase 
Assay. 
16.  Repeat steps 2-14      
17.  Using homophthalic acid and b-Lactamase Assay, make a 500mM concentration in order to 
make additional concentration strengths to be tested. Add 180.16mg of homophthalic acid with 
3mL of b-Lactamase Assay. 
18.  Repeat steps 2-14. 
19.  Using 1,2 Phenylenediacetic acid and b-Lactamase Assay, make a 500mM concentration in 
order to make additional concentration strengths to be tested. Add 291.27mg of 1,2 
Phenylenediacetic acid with 3mL b-Lactamase Assay. 
20.  Repeat steps 2-14.   
21.  Run a blank sample consisting of 50uL and 30uL Enzymatic Reaction Mix to establish a 
































Figure 5: Beta-Lactamase activity graphs for terephthalic acid, phthalic acid, and 1,2-phenylene 








Figure 6: The beta-lactamase activity is shown at each concentration level of the three inhibitors 






The data analyse consisted of graphing the increase in absorbance at 490 nm as a function of 
reaction time for each concentration of the inhibitor and getting an average slope for the two 
trials. The average slope of activity was then divided by that of activity without an inhibitor to 
determine the percent activity for the varying concentrations. The percent activity was then 
graphed against common log of the inhibitor concentration. These values were regraphed to 
construct the Hill plot to determine the Hill coefficient and at what concentration each molecule 
inhibited b-lactamase 50%(IC 50). The Hill plot was constructed by plotting Log (Y/(1-Y)) as a 
function of Log X, where Y is the percent activity and X is the molar concentration of the 
inhibitor.  The Hill coefficient and IC50 were determined from the slope and the x-intercept of the 
Hill plot. The best fit curve was obtained using the following equation: 
 
Where Max is the maximum activity, Min is the minimum activity, X is the molar concentration of 















The purpose of this study was to determine if phthalic acid, terephthalic acid, and 1,2-
phenylenediacetic acid could inhibit beta-lactamase activity and then compare them against one 
another by finding the IC50 for each inhibitor. In the research study referenced in the intro, it 
was inferred that the carboxyl groups of 4-butyl-3-methylphthalic acid were the major factor that 
lead it to being an inhibitor [3]. Due to this information, it was predicted that 1,2-
phenylenediacetic acid would be the best inhibitor due to its large functional groups and their 
close placement to one another on the molecule. It was determined that these inhibitors were 
not very successful inhibitors of beta-lactamase. The results seem to be confirmed with the 
docking simulation. The simulation shows that the inhibitors chosen don’t specifically bond to 
the active site, making it a non-successful inhibitor. 
The prediction that 1,2-phenylenediacetic acid would be the best inhibitor was not supported by 
the data gathered from this experiment. Looking at the graph in Figure 6, it is clear that all of the 
molecules inhibited the beta-lactamase activity. The data showed that actually terephthalic acid 
was the most inhibitory of beta-lactamase. The IC50 for terephthalic acid was not able to be 
determined, however the smallest concentration of terephthalic acid tested,1.5 micromolar, 
yielded a b-lactamase activity of 34%, in other words an inhibition rate of 66%. The IC 50 values 
found for phthalic acid and 1,2-phenylenediacetic acid was 8.0 +/- 0.6 mM and 2.8 +/- 0.8 mM, 
respectively. This shows that 1,2-phenylenediacetic acid was slightly better inhibitor than 
phthalic acid. Phthalic acid and 1,2-phenylenediacetic acid are both similar in structure and 
inhibition of beta-lactamase. Terephthalic is the most different in structure with its carboxyl 
groups spread out the furthest. This could point towards the distance of the carboxyl groups 
having a greater impact on inhibition of beta-lactamase. Even though these molecules showed 
the ability to inhibit b-lactamase activity, it is unlikely that these molecules would make it to the 
clinical level due to the large concentration of each molecule needed to inhibit b-lactamase 
activity. Clinical drugs used are in nanomolar concentration while this experiment showed that 
micromolar concentrations were necessary for inhibition.  
One challenge that arose during this experiment was the limited source of beta-lactamase 
buffer. The protocol required a lot of it and only 25mL was able to be purchased due to high 
costs. As seen in Fig.4, phthalic acid has more data points than 1,2-phenylenediacetic acid and 
terephthalic acid. This was due to phthalic acid being used first to determine what 
concentrations would produce 50% inhibition on b-lactamase. Once determining a set of 
concentrations that provided a thorough range of inhibition, those concentrations were also 
used for terephthalic acid and 1,2-phenylenediacetic acid. Another challenge that arose was 
that during the pipetting of the enzyme reaction mix into the wells, air bubbles would form. It was 
difficult to get rid of all the air bubbles and they may have impacted the data obtained. The 
original protocol also called for the potential inhibitors to be dissolved into beta-lactamase buffer 
but due to the insolubility of the inhibitors, DMSO had to be used instead. The activity versus 
time graph was also a challenge to deal with due to the graph leveling off fast and being non-
linear. This occured when low concentrations of the inhibitors were used and introduced lare 
errors when the activity of beta-lactamase was high.  
 
Conclusion 
According to the results gathered from this experiment, phthalic acid, 1,2-phenylenediacetic 
acid, and terephthalic acid are all inhibitors or b-lactamase activity. While it was predicted that 
1,2-phenylenediacetic acid would have the best inhibition, it was actually terephthalic acid with 
the best rate of inhibition. IC 50 values found for phthalic acid and 1,2-phenylenediacetic acid 
was 8.0 +/- 0.6 mM and 2.8 +/- 0.8 mM, respectively. respectively. Even though these 
molecules showed the ability to inhibit beta-lactamase activity, it is unlikely that these molecules 
would make it to the clinical level due to the large amount of each molecule needed to inhibit 
beta-lactamase activity. Clinical drugs used are in the concentration of nano molar while this 
experiment showed that micro molar concentrations were necessary for inhibition. In the future, 
I hope other students continues this research and take a further look into the effect of the 
distance of the carboxyl groups has on the inhibition of beta-lactamase activity. 
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The purpose of this study was to determine if phthalic acid, terephthalic acid, and 1,2-
phenylenediacetic acid could inhibit beta-lactamase activity and then compare them against 
one another by finding the IC50 for each inhibitor. In the research study referenced in the 
intro, it was inferred that the carboxyl groups of 4-butyl-3-methylphthalic acid were the 
major factor that lead it to being an inhibitor (3). Due to this information, it was predicted 
that 1,2-phenylenediacetic acid would be the best inhibitor due to its longer and more 
flexible functional groups and their close placement to one another on the molecule. It was 
determined that these inhibitors were not very successful inhibitors of beta-lactamase. The 
results seem to be confirmed with the docking simulation. The simulation shows that the 
inhibitors chosen don’t specifically bond to the active site, making them nonspecific 
inhibitors.
The prediction that 1,2-phenylenediacetic acid would be the best inhibitor was not 
supported by the data gathered from this experiment. Looking at the graph in Figure 6, it is 
clear that all of the molecules inhibited the beta-lactamase activity. The data showed that 
actually terephthalic acid was the most inhibitory of beta-lactamase. The IC50 for 
terephthalic acid could not be determined, however the smallest concentration of 
terephthalic acid tested,1.5 mM, yielded a beta-lactamase activity of 34%, in other words an 
inhibition rate of 66%. The IC 50 values found for phthalic acid and 1,2-phenylenediacetic 
acid was 8.0 ± 0.6 mM and 2.8 ± 0.8 mM, respectively. This shows that 1,2-phenylenediacetic 
acid was slightly better inhibitor than phthalic acid. Phthalic acid and 1,2-phenylenediacetic 
acid are both similar in structure and inhibition of beta-lactamase. Terephthalic is the most 
different in structure with its carboxyl groups spread out the furthest. This could point 
towards the distance of the carboxyl groups having a greater impact on inhibition of beta-
lactamase. Even though these molecules showed the ability to inhibit b-lactamase activity, it is 
unlikely that these molecules would make it to the clinical level due to the large 
concentration of each molecule needed to inhibit beta-lactamase activity. Clinical drugs used 
are in nanomolar concentration while this experiment showed that millimolar
concentrations were necessary for inhibition. 
One challenge that arose during this experiment was the limited source of beta-lactamase 
buffer. The protocol required a lot of it and only 25mL was able to be purchased due to high 
costs. As seen in Fig.6, phthalic acid has more data points than 1,2-phenylenediacetic acid and 
terephthalic acid. This was due to phthalic acid being used first to determine what 
concentrations would produce 50% inhibition on beta-lactamase. Once determining a set of 
concentrations that provided a thorough range of inhibition, those concentrations were also 
used for terephthalic acid and 1,2-phenylenediacetic acid. Another challenge that arose was 
that during the pipetting of the enzyme reaction mix into the wells, air bubbles would form. 
It was difficult to get rid of all the air bubbles and they may have impacted the data obtained. 
The original protocol also called for the potential inhibitors to be dissolved into beta-
lactamase buffer but due to the insolubility of the inhibitors, DMSO had to be used instead. 
The activity versus time graph was also a challenge to deal with due to the graph leveling off 
fast and being non-linear. This occurred when low concentrations of the inhibitors were used 
and introduced large errors when the activity of beta-lactamase was high.
DISCUSSION
As a Cell and Molecular major with a Pre-Pharmacy emphasis, medicine has been 
an interest of mine. The major cause of increasing bacterial resistance to beta-
lactam antibiotics is due to the expression of the enzyme, beta-lactamase, in 
bacteria. This leads to the inactivation of the antibiotics and preventing cell death. 
The currently known inhibitors of beta-lactamase are clavulanic acid, sulbactam, 
and tazobactam. These are the only inhibitors that have reached clinical 
importance. Phthalic acid derivatives have been identified as potential inhibitors. 
Phthalic acid, terephthalic acid, and 1,2-phenylenediacetic acid were tested for 
beta-lactamase inhibition at various concentrations to determine the IC50 values. 
The data showed that terephthalic acid was the most inhibitory of beta-lactamase. 
The IC50 for terephthalic acid could not be fully determined, however the lowest 
concentration of terephthalic acid tested,1.5 mM, yielded a beta-lactamase activity 
of 34%, in other words, an 66% inhibition. The IC50 values for phthalic acid and 
1,2-phenylenediacetic acid were 8.0 ± 0.6 mM and 2.8 ± 0.8 mM, respectively. 
Phthalic acid and 1,2-phenylenediacetic acid are both similar in structure and 
inhibition of beta lactamase. The structure of terephthalic is the most different 
with its two carboxyl groups spread out the furthest. This could point towards the 
distance of the carboxyl groups having a greater impact on inhibition of beta-
lactamase. Although all three phthalic acid derivatives showed the ability to inhibit 
beta-lactamase, it is unlikely that these molecules would make it to the clinical level 
due to the high concentration of each molecule needed to inhibit beta-lactamase 
activity. Clinical drugs used are in the concentration of nanomolar while this 
experiment showed that millimolar concentrations were necessary for inhibition. 
In the future, I hope another student continues this research and takes a further 
look into the effect of the distance of the carboxyl group has on the inhibition of 
beta-lactamase activity. .
ABSTRACT
Beta-lactam antibiotics work by blocking cell wall synthesis of the bacteria and are 
a common drug used to treat bacterial infections. A major problem developing 
today in the world is the increase in bacteria being resistant to beta-lactam 
antibiotics(1,4). The major cause of increasing bacterial resistance to beta-lactam 
antibiotics is due to the expression of the enzyme beta-lactamase in bacteria (1,4). 
Beta-lactamase is able to hydrolyzes beta-lactam antibiotics in bacteria that contain 
the beta-lactamase coding gene(1). This leads to the inactivating of the antibiotics 
and preventing cell death. This problem has provided a challenge in finding beta-
lactamase inhibitors so these beta-lactam antibiotics can continue to kill bacterial 
infections.
There are a few inhibitors that have been found already for beta-lactamase. The 
currently know inhibitors are clavulanic acid, sulbactam, and tazobactam(2). These 
are the only three inhibitors that have reached clinical importance(2). However, 
some other potential inhibitors of beta-lactamase have been identified, including 
phthalic acid derivatives. 
A research study performed by Yukiko Hiraiwa, Akihiro Morinaka, Takayoshi 
Fukushima, and Toshiaki Kudo has given evidence to this. In their study, they set out 
to find metallo-beta-lactamase inhibitory activity of phthalic acid derivatives and 
found that the two carboxyl groups of phthalic acid derivative compounds might 
interact with zinc in the active site of the enzyme, which could then inhibit the 
beta-lactamase produced (3). They then fixed the two carboxyl groups and 
investigated the effect of substitution of the phenyl ring on metallo-beta-lactamase 
inhibitory activity(3). In the experiment 4-butyl-3-methylphthalic acid was 
recognized as a metallo-beta-lactamase inhibitor. The structure–activity 
relationship study of substituted phthalic acids afforded 3-phenylphthalic acid 
derivatives as potent metallo-beta-lactamase inhibitors(3).
Figure 1: Clavulanic acid
INTRODUCTION
MATERIALS and METHODOLOGY
Phthalic acid, terephthalic acid, 1,2-phenylenediacetic acid, the Beta-Lactamase 
Screening Kit ( MAK222) including beta-lactamase, beta-lactamase assay buffer and 
clavulanic acid, and nitrocefin were purchased from Sigma Aldrich. Concentrations 
of 500mM of Phthalic acid, terephthalic acid, and 1,2-phenylenediacetic acid were 
made using the the drugs and DMSO. From the 500mM concentration, 
concentrations of 1.5 mM, 2.5 mM, 5 mM, 25 mM, and 50 mM were made for each 
drug. 30 µl of enzymatic reaction mix consisting of 29 µL b-Lactamase Assay Buffer 
and 1 µL Nitrocefin was added to 20 µL of each drug. The drug mixtures were 
then incubated at 25 °C for 10 minutes. A blank sample without inhibitor was ran 
to establish a 100% activity level. Clavulanic acid was also used as a known 
inhibitor of beta-lactamase activity. 30 µL enzyme was added to initiate the 
reaction. The absorbance at 490 nm was measured using a SpectraMax M5 
microplate reader from Molecular Devices in kinetic mode for 10 minutes, taking 
the absorbance reading every 30 seconds. The data was then used to see beta-
lactamase activity over time for each concentration to establish an activity curve.
.
RESULTS
Inhibition of beta-lactamase by clavulanate. Trapped 
intermediates in cryo crystallographic studies
(5,6,7). 
Docking simulation of phthalic acid at the 
active site of beta-lactamase (1BLC). The 
calculated KI was 2.2 mM (8).
Docking simulation of Terephthalic acid at 
the active site of beta-lactamase 
(1BLC). The calculated KI was 2.1 mM (8).
Docking simulation of 1,2-
Phenylenediacetic acid at the active site 
of beta-lactamase (1BLC). The 
calculated KI was 1.4 mM (8).
My proposal is to use the beta-lactamase 
enzyme activity to find the inhibiting ability 
for phthalic acid, 1,2-phenylenediacetic acid, 
and terephthalic acid.
Beta-lactamase enzyme activity was assayed 
colorimetrically at 490 nm using the Sigma 
Aldrich Beta-Lactamase Screening Kit 
(MAK222). The activity was measured by 
monitoring a colored product by hydrolyzing 
the lactam ring of a substrate, nitrocefin. The 
structure of nitrocefin is shown below.
Figure 5: Beta-lactamase activity 
graphs for phthalic acid, 1,2-
phenylenediacetic acid, and 
terephthalic acid. The two lines 
represent the two trials for each 
inhibitor.
The Hill coefficient and IC50 were 
determined from the slope and the 
antilog of the x-intercept of the Hill plot. 
Figure 6:  Percent activity versus log 
concentration
The best fit curve was obtained using 
the following equation:
The data analysis consisted of graphing the increase in absorbance at 490 nm as a function 
of reaction time for each concentration of the inhibitor and getting an average slope for 
the two trials. The average slope of activity was then divided by that of activity without an 
inhibitor to determine the percent activity for the varying concentrations. The percent 
activity was then graphed against common log of the inhibitor concentration. These values 
were then used to construct the Hill plot to determine the Hill coefficient and the 
concentration of each molecule at 50% beta-lactamase activity (IC50). The Hill plot was 
constructed by plotting Log (Y/(100-Y)) as a function of Log X, where Y is the percent 
activity and X is the molar concentration of the inhibitor. 
where Max is the maximum activity, Min is the minimum activity, X is the molar 
concentration of the inhibitor, and Hill is the Hill coefficient from the Hill plot. The percent 
beta-lactamase activity is shown at each concentration level of the three inhibitors tested. 
The error bar are individually set to the error for each data point gathered.
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CONCLUSION
According to the results gathered from this experiment, phthalic acid, 1,2-
phenylenediacetic acid, and terephthalic acid are all inhibitors or b-lactamase activity. 
While it was predicted that 1,2-phenylenediacetic acid would have the best inhibition, it 
was actually terephthalic acid with the best rate of inhibition. Even though these 
molecules showed the ability to inhibit beta-lactamase activity, it is unlikely that these 
molecules would make it to the clinical level due to the large amount of each molecule 
needed to inhibit beta-lactamase activity. Clinical drugs used are in the concentration of 
nanomolar while this experiment showed that millimolar concentrations were necessary 
for inhibition. In the future, I hope other students continues this research and take a 
further look into the effect of the distance of the carboxyl groups has on the inhibition of 
beta-lactamase activity.
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Figure 4: Terephthalic Acid

